• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SUMOylation 修饰泛素连接酶 IDOL 会降低 LDL 受体水平,这一过程可被 SENP1 逆转。

SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1.

机构信息

Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China.

Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China.

出版信息

J Biol Chem. 2021 Jan-Jun;296:100032. doi: 10.1074/jbc.RA120.015420. Epub 2020 Nov 23.

DOI:10.1074/jbc.RA120.015420
PMID:33154164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7948399/
Abstract

Inducible degrader of the low-density lipoprotein receptor (IDOL) is an E3 ubiquitin ligase mediating degradation of low-density lipoprotein (LDL) receptor (LDLR). IDOL also controls its own stability through autoubiquitination, primarily at lysine 293. Whether IDOL may undergo other forms of posttranslational modification is unknown. In this study, we show that IDOL can be modified by small ubiquitin-like modifier 1 at the K293 residue at least. The SUMOylation of IDOL counteracts its ubiquitination and augments IDOL protein levels. SUMOylation and the associated increase of IDOL protein are effectively reversed by SUMO-specific peptidase 1 (SENP1) in an activity-dependent manner. We further demonstrate that SENP1 affects LDLR protein levels by modulating IDOL. Overexpression of SENP1 increases LDLR protein levels and enhances LDL uptake in cultured cells. On the contrary, loss of SENP1 lowers LDLR levels in an IDOL-dependent manner and reduces LDL endocytosis. Collectively, our results reveal SUMOylation as a new regulatory posttranslational modification of IDOL and suggest that SENP1 positively regulates the LDLR pathway via deSUMOylation of IDOL and may therefore be exploited for the treatment of cardiovascular disease.

摘要

诱导型低密度脂蛋白受体(IDOL)降解酶是一种 E3 泛素连接酶,介导低密度脂蛋白受体(LDLR)的降解。IDOL 还通过自身泛素化来控制自身的稳定性,主要在赖氨酸 293 上。IDOL 是否可能发生其他形式的翻译后修饰尚不清楚。在本研究中,我们表明 IDOL 至少可以在 K293 残基上被小泛素样修饰物 1 修饰。IDOL 的 SUMO 化可拮抗其泛素化并增加 IDOL 蛋白水平。SUMO 特异性肽酶 1(SENP1)以活性依赖的方式有效地逆转 SUMO 化及其伴随的 IDOL 蛋白增加。我们进一步证明,SENP1 通过调节 IDOL 影响 LDLR 蛋白水平。SENP1 的过表达增加了培养细胞中的 LDLR 蛋白水平并增强了 LDL 摄取。相反,SENP1 的缺失以 IDOL 依赖的方式降低 LDLR 水平并减少 LDL 内吞。总之,我们的结果揭示了 SUMO 化是 IDOL 的一种新的翻译后修饰调节方式,并表明 SENP1 通过 IDOL 的去 SUMO 化正向调节 LDLR 途径,因此可能被用于心血管疾病的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1c/7948399/611b5f116292/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1c/7948399/8e7d20101d9a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1c/7948399/5665b83acf77/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1c/7948399/9334c26b3beb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1c/7948399/f47b3f9a70ce/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1c/7948399/b4832536d509/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1c/7948399/611b5f116292/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1c/7948399/8e7d20101d9a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1c/7948399/5665b83acf77/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1c/7948399/9334c26b3beb/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1c/7948399/f47b3f9a70ce/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1c/7948399/b4832536d509/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f1c/7948399/611b5f116292/gr6.jpg

相似文献

1
SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1.SUMOylation 修饰泛素连接酶 IDOL 会降低 LDL 受体水平,这一过程可被 SENP1 逆转。
J Biol Chem. 2021 Jan-Jun;296:100032. doi: 10.1074/jbc.RA120.015420. Epub 2020 Nov 23.
2
The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOL.去泛素化酶 USP2 通过拮抗 E3 泛素连接酶 IDOL 来调节 LDLR 途径。
Circ Res. 2016 Feb 5;118(3):410-9. doi: 10.1161/CIRCRESAHA.115.307298. Epub 2015 Dec 14.
3
Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor.通过 LDLR 的 E3 泛素连接酶诱导降解物对脂蛋白受体进行转录后调控。
Curr Opin Lipidol. 2012 Jun;23(3):213-219. doi: 10.1097/MOL.0b013e3283532947.
4
Distinct functional domains contribute to degradation of the low density lipoprotein receptor (LDLR) by the E3 ubiquitin ligase inducible Degrader of the LDLR (IDOL).低密度脂蛋白受体(LDLR)的 E3 泛素连接酶诱导 LDLR 降解物(IDOL)的不同功能域有助于 LDLR 的降解。
J Biol Chem. 2011 Aug 26;286(34):30190-9. doi: 10.1074/jbc.M111.249557. Epub 2011 Jul 6.
5
Structural analysis of the LDL receptor-interacting FERM domain in the E3 ubiquitin ligase IDOL reveals an obscured substrate-binding site.结构分析 LDL 受体相互作用 FERM 域在 E3 泛素连接酶 IDOL 中揭示了一个隐藏的底物结合位点。
J Biol Chem. 2020 Sep 25;295(39):13570-13583. doi: 10.1074/jbc.RA120.014349. Epub 2020 Jul 29.
6
The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation.LXR-IDOL 轴定义了 LDLR 内化和溶酶体降解的网格蛋白、小窝蛋白和动力蛋白非依赖性内吞途径。
J Lipid Res. 2013 Aug;54(8):2174-2184. doi: 10.1194/jlr.M037713. Epub 2013 Jun 3.
7
IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.IDOL 促进了低密度脂蛋白受体的网格蛋白非依赖内吞作用和多泡体介导的溶酶体降解。
Mol Cell Biol. 2013 Apr;33(8):1503-14. doi: 10.1128/MCB.01716-12. Epub 2013 Feb 4.
8
IDOL, inducible degrader of low-density lipoprotein receptor, serves as a potential therapeutic target for dyslipidemia.低密度脂蛋白受体诱导降解物(IDOL)是血脂异常的潜在治疗靶点。
Med Hypotheses. 2016 Jan;86:138-42. doi: 10.1016/j.mehy.2015.11.010. Epub 2015 Nov 14.
9
Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists.靶向破坏 idol 基因可改变固醇和肝 X 受体激动剂对低密度脂蛋白受体的细胞调控。
Mol Cell Biol. 2011 May;31(9):1885-93. doi: 10.1128/MCB.01469-10. Epub 2011 Feb 22.
10
The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2.E3 泛素连接酶 IDOL 诱导 LDLR 家族成员 VLDLR 和 ApoER2 的降解。
J Biol Chem. 2010 Jun 25;285(26):19720-6. doi: 10.1074/jbc.M110.123729. Epub 2010 Apr 28.

引用本文的文献

1
IMM-H007 promotes hepatic cholesterol and triglyceride metabolism by activating AMPK to attenuate hypercholesterolemia.IMM-H007通过激活AMPK促进肝脏胆固醇和甘油三酯代谢,以减轻高胆固醇血症。
Acta Pharm Sin B. 2025 Aug;15(8):4047-4063. doi: 10.1016/j.apsb.2025.05.015. Epub 2025 May 21.
2
Zebrafish mylipb attenuates antiviral innate immunity through two synergistic mechanisms targeting transcription factor irf3.斑马鱼 miyelpB 通过靶向转录因子 irf3 的两种协同机制来减弱抗病毒先天免疫。
PLoS Pathog. 2024 May 13;20(5):e1012227. doi: 10.1371/journal.ppat.1012227. eCollection 2024 May.
3
Fatty acid-binding proteins 3, 7, and 8 bind cholesterol and facilitate its egress from lysosomes.

本文引用的文献

1
POST1/C12ORF49 regulates the SREBP pathway by promoting site-1 protease maturation.POST1/C12ORF49 通过促进位点 1 蛋白酶成熟来调节 SREBP 通路。
Protein Cell. 2021 Apr;12(4):279-296. doi: 10.1007/s13238-020-00753-3. Epub 2020 Jul 14.
2
IDOL regulates systemic energy balance through control of neuronal VLDLR expression.IDOL 通过控制神经元 VLDLR 的表达来调节全身能量平衡。
Nat Metab. 2019 Nov;1(11):1089-1100. doi: 10.1038/s42255-019-0127-7. Epub 2019 Oct 28.
3
Therapeutic IDOL Reduction Ameliorates Amyloidosis and Improves Cognitive Function in APP/PS1 Mice.
脂肪酸结合蛋白 3、7 和 8 结合胆固醇并促进其从溶酶体中排出。
J Cell Biol. 2024 Apr 1;223(4). doi: 10.1083/jcb.202211062. Epub 2024 Mar 1.
4
Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies.靶向代谢疾病中的蛋白质修饰:分子机制与靶向治疗。
Signal Transduct Target Ther. 2023 May 27;8(1):220. doi: 10.1038/s41392-023-01439-y.
5
Lysosomal cholesterol accumulation is commonly found in most peroxisomal disorders and reversed by 2-hydroxypropyl-β-cyclodextrin.溶酶体胆固醇积累在大多数过氧化物酶体疾病中很常见,并可被 2-羟丙基-β-环糊精逆转。
Sci China Life Sci. 2023 Aug;66(8):1786-1799. doi: 10.1007/s11427-022-2260-4. Epub 2023 Mar 23.
6
Ubiquitin and its relatives as wizards of the endolysosomal system.泛素及其相关蛋白作为内溶酶体系统的巫师。
J Cell Sci. 2023 Feb 15;136(4). doi: 10.1242/jcs.260101. Epub 2023 Feb 24.
7
Isocoumarins and Benzoquinones with Their Proprotein Convertase Subtilisin/Kexin Type 9 Expression Inhibitory Activities from Dried Roots of .来自……干燥根中具有前蛋白转化酶枯草杆菌蛋白酶/克新9型表达抑制活性的异香豆素和苯醌类化合物 。 (你提供的原文似乎不完整,“from Dried Roots of.”后面缺少具体植物名称等信息)
ACS Omega. 2022 Dec 8;7(50):47296-47305. doi: 10.1021/acsomega.2c06660. eCollection 2022 Dec 20.
治疗性 IDOL 降低可改善 APP/PS1 小鼠的淀粉样变性并改善认知功能。
Mol Cell Biol. 2020 Mar 30;40(8). doi: 10.1128/MCB.00518-19.
4
Competitive oxidation and ubiquitylation on the evolutionarily conserved cysteine confer tissue-specific stabilization of Insig-2.竞争氧化和泛素化作用在进化上保守的半胱氨酸上赋予 Insig-2 的组织特异性稳定。
Nat Commun. 2020 Jan 17;11(1):379. doi: 10.1038/s41467-019-14231-w.
5
Mechanisms and regulation of cholesterol homeostasis.胆固醇稳态的机制和调节。
Nat Rev Mol Cell Biol. 2020 Apr;21(4):225-245. doi: 10.1038/s41580-019-0190-7. Epub 2019 Dec 17.
6
Regulation of glucose and lipid metabolism in health and disease.健康与疾病中的糖脂代谢调控。
Sci China Life Sci. 2019 Nov;62(11):1420-1458. doi: 10.1007/s11427-019-1563-3. Epub 2019 Oct 31.
7
IDOL G51S Variant Is Associated With High Blood Cholesterol and Increases Low-Density Lipoprotein Receptor Degradation.IDOL G51S 变异与高胆固醇血症有关,并增加低密度脂蛋白受体降解。
Arterioscler Thromb Vasc Biol. 2019 Dec;39(12):2468-2479. doi: 10.1161/ATVBAHA.119.312589. Epub 2019 Oct 10.
8
Cholesterol transport through the peroxisome-ER membrane contacts tethered by PI(4,5)P and extended synaptotagmins.胆固醇通过由 PI(4,5)P 和延伸突触融合蛋白 tether 的过氧化物酶体-内质网膜接触进行运输。
Sci China Life Sci. 2019 Sep;62(9):1117-1135. doi: 10.1007/s11427-019-9569-9. Epub 2019 May 22.
9
PCSK9 inhibitors: clinical evidence and implementation.PCSK9 抑制剂:临床证据与应用。
Nat Rev Cardiol. 2019 Mar;16(3):155-165. doi: 10.1038/s41569-018-0107-8.
10
SUMO-specific proteases and isopeptidases of the SENP family at a glance.SUMO 特异性蛋白酶和 SENP 家族的异构肽酶一览。
J Cell Sci. 2018 Mar 20;131(6):jcs211904. doi: 10.1242/jcs.211904.